Preclinical safety evaluation using nonrodent species: An industry/welfare project to minimize dog use

ILAR Journal

Volumn 43, Issue SUPPL., 2002, Pages

  Smith, David ^a   Broadhead, Caren ^a   Descotes, Gerard ^a   Fosse, Richard ^a   Hack, Ruediger ^a   Krauser, Klaus ^a   Pfister, Rudolf ^a   Phillips, Barry ^a   Rabemampianina, Yvon ^a   Sanders, James ^a   Sparrow, Sue ^a   Stephan Gueldner, Markus ^a   Jacobsen, Soren Dyring ^a  

^a NONE

Author keywords

Alternatives; Animal use; Dogs; Laboratory animal sciences; Toxicity tests

Indexed keywords

DRUG;

ACUTE TOXICITY; ANIMAL TESTING REDUCTION; ANIMAL TESTING REPLACEMENT; ANIMAL USE; ARTICLE; CHRONIC TOXICITY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DOG; DRUG INDUSTRY; DRUG SAFETY; EUROPE; EVALUATION; EXPERIMENTAL ANIMAL WELFARE; NONHUMAN; PRACTICE GUIDELINE; REVIEW; SPECIES DIFFERENCE; TOXICITY TESTING; TOXICOLOGY; VALIDATION PROCESS;

ANIMALIA; CANIS FAMILIARIS;

EID: 6444244789     PISSN: 10842020     EISSN: None     Source Type: Journal    
DOI: 10.1093/ilar.43.suppl_1.s39     Document Type: Article

References (6)

1. Prospects for reducing and refining the use of dogs in the regulatory toxicity testing of pharmaceuticals
2. The approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes
3. Statistics of scientific procedures on living animals, Great Britain 1999
4. Concordance of the toxicity of pharmaceuticals in humans and in animals